金融界2025年7月7日消息，国家知识产权局信息显示，开元制药（安徽）有限公司取得一项名为“一种用于磷霉素左磷右胺盐合成的过滤装置”的专利，授权公告号CN223055248U，申请日期为2024年07月。
专利摘要显示，本实用新型提供一种用于磷霉素左磷右胺盐合成的过滤装置，具体涉及制药生产技术领域，包括筒型的过滤罐，过滤罐两端设有封头，封头上端和下端分别设有进口和出口，过滤罐内设有滤袋，滤袋上沿与过滤罐边缘紧密贴合连接，滤袋内设有上开口的滤筒，滤筒上边沿与滤袋上沿紧密贴合连接，滤筒内部设有若干滤板，滤板与滤筒之间为可拆合结构，且滤筒外圈、滤板上均设有若干滤孔。
天眼查资料显示，开元制药（安徽）有限公司，成立于2021年，位于宿州市，是一家以从事批发业为主的企业。企业注册资本6000万人民币。通过天眼查大数据分析，开元制药（安徽）有限公司参与招投标项目10次，专利信息8条，此外企业还拥有行政许可74个。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.